Skip to Content
You are currently on the new version of our website. Access the old version .

20 Results Found

  • Review
  • Open Access
21 Citations
6,054 Views
13 Pages

31 July 2022

Immunophenotypic characterization of leukemic cells with the use of flow cytometry (FC) is a fundamental tool in acute lymphoblastic leukemia (ALL) diagnostics. A variety of genetic aberrations underlie specific B-cell precursor ALL (BCP-ALL) subtype...

(This article belongs to the Special Issue Genomic Aberrations in Hematologic Malignancies)
  • Review
  • Open Access
14 Citations
8,651 Views
19 Pages

Overview on Aneuploidy in Childhood B-Cell Acute Lymphoblastic Leukemia

  • Kinga Panuciak,
  • Emilia Nowicka,
  • Angelika Mastalerczyk,
  • Joanna Zawitkowska and ,
  • Maciej Niedźwiecki and
  • Monika Lejman
  • + 1 author+ 0 author

Recent years have brought significant progress in the treatment of B-cell acute lymphoblastic leukemia (ALL). This was influenced by both the improved schemes of conventionally used therapy, as well as the development of new forms of treatment. As a...

(This article belongs to the Section Molecular Biology)
  • Article
  • Open Access
26 Citations
4,995 Views
25 Pages

Optical Genome Mapping Reveals the Complex Genetic Landscape of Myeloma

  • Amélie Giguère,
  • Isabelle Raymond-Bouchard,
  • Vanessa Collin,
  • Jean-Sébastien Claveau and ,
  • Josée Hébert and
  • Richard LeBlanc
  • + 1 author+ 0 author

22 September 2023

Fluorescence in situ hybridization (FISH) on enriched CD138 plasma cells is the standard method for identification of clinically relevant genetic abnormalities in multiple myeloma. However, FISH is a targeted analysis that can be challenging due to t...

(This article belongs to the Special Issue Optical Genome Mapping in Hematological Malignancies)
  • Article
  • Open Access
2 Citations
2,740 Views
25 Pages

Loss of Heterozygosity in Pediatric Acute Lymphoblastic Leukemia and Its Prognostic Impact: A Retrospective Study

  • Borys Styka,
  • Gabriela Ręka,
  • Aleksandra Ozygała,
  • Mariola Janiszewska and ,
  • Magdalena Stelmach,
  • Paulina Skowera,
  • Zuzanna Urbańska and
  • Monika Lejman
  • + 3 authors+ 0 author

29 July 2025

Background: In childhood acute lymphoblastic leukemia (ALL), in addition to classical chromosomal abnormalities, loss of heterozygosity (LOH), including copy-neutral LOH, is also observed. While LOH has been described in the literature, its clinical...

(This article belongs to the Section Molecular Cancer Biology)
  • Article
  • Open Access
1 Citations
1,216 Views
5 Pages

14 June 2019

Intrachromosomal amplification (iAMP) of chromosome 21 entity is associated with a dismal outcome in B cell Acute Lymphoblastic Leukemia (B-ALL). This cytogenetic abnormality is caused by a novel mechanism; breakage-fusion-bridge cycles followed by c...

  • Article
  • Open Access
3 Citations
6,908 Views
17 Pages

Go with the Flow—Early Assessment of Measurable Residual Disease in Children with Acute Lymphoblastic Leukemia Treated According to ALL IC-BFM2009

  • Katarzyna Pawinska-Wasikowska,
  • Karolina Bukowska-Strakova,
  • Marta Surman,
  • Monika Rygielska and ,
  • Beata Sadowska,
  • Teofila Ksiazek,
  • Tomasz Klekawka,
  • Aleksandra Wieczorek,
  • Szymon Skoczen and
  • Walentyna Balwierz
  • + 5 authors+ 0 author

30 October 2022

Measurable residual disease (MRD) is a well-known tool for the evaluation of the early response to treatment in patients with acute lymphoblastic leukemia (ALL). In respect to predicting the relapse the most informative cut-off and time point of MRD...

(This article belongs to the Special Issue Measurable Residual Disease in Cancer)
  • Article
  • Open Access
5 Citations
3,151 Views
11 Pages

Spectrum of Genetic Mutations in Korean Pediatric Acute Lymphoblastic Leukemia

  • Jae Won Yoo,
  • Ari Ahn,
  • Jong-Mi Lee,
  • Suejung Jo and ,
  • Seongkoo Kim,
  • Jae Wook Lee,
  • Bin Cho,
  • Yonggoo Kim,
  • Myungshin Kim and
  • Nack-Gyun Chung
  • + 5 authors+ 0 author

26 October 2022

The wide application of next-generation sequencing (NGS) technologies has led to the discovery of multiple genetic alterations in pediatric acute lymphoblastic leukemia (ALL). In this work, we aimed to investigate the mutational spectrum in pediatric...

(This article belongs to the Special Issue Clinical and Molecular Diagnosis of Hematologic Malignancies)
  • Article
  • Open Access
8 Citations
2,792 Views
17 Pages

Application of Optical Genome Mapping for the Diagnosis and Risk Stratification of Myeloid and Lymphoid Malignancies

  • Lucía Ballesta-Alcaraz,
  • Mónica Bernal,
  • Jose Ramón Vilchez,
  • Jorge Antonio Palacios and ,
  • Pilar Jiménez,
  • Pilar Garrido,
  • Juan Francisco Gutiérrez-Bautista and
  • Francisco Ruiz-Cabello
  • + 3 authors+ 0 author

Optical genome mapping (OGM) is a novel, high-resolution technology for genome-wide detection of structural variants, offering clear advantages over conventional cytogenetics in hematologic malignancies. We applied OGM to a large cohort of patients w...

(This article belongs to the Section Molecular Oncology)
  • Article
  • Open Access
2 Citations
3,185 Views
14 Pages

Identification of Molecular Subtypes of B-Cell Acute Lymphoblastic Leukemia in Mexican Children by Whole-Transcriptome Analysis

  • Norberto Sánchez-Escobar,
  • María de los Ángeles Romero-Tlalolini,
  • Haydeé Rosas-Vargas,
  • Elva Jiménez-Hernández and ,
  • Juan Carlos Núñez Enríquez,
  • Angélica Rangel-López,
  • José Manuel Sánchez López,
  • Daniela Rojo-Serrato,
  • América Mariana Jasso Mata and
  • Minerva Mata-Rocha
  • + 14 authors+ 9 authors

B-lineage acute lymphoblastic leukemia (B-ALL) is classified into more than 20 molecular subtypes, and next-generation sequencing has facilitated the identification of these with high sensitivity. Bulk RNA-seq analysis of bone marrow was realized to...

(This article belongs to the Special Issue Novel Agents and Molecular Research in Multiple Myeloma)
  • Article
  • Open Access
57 Citations
6,595 Views
19 Pages

The Clinical Utility of Optical Genome Mapping for the Assessment of Genomic Aberrations in Acute Lymphoblastic Leukemia

  • Jonathan Lukas Lühmann,
  • Marie Stelter,
  • Marie Wolter,
  • Josephine Kater and ,
  • Jana Lentes,
  • Anke Katharina Bergmann,
  • Maximilian Schieck,
  • Gudrun Göhring,
  • Anja Möricke and
  • Doris Steinemann
  • + 10 authors+ 5 authors

30 August 2021

Acute lymphoblastic leukemia (ALL) is the most prevalent type of cancer occurring in children. ALL is characterized by structural and numeric genomic aberrations that strongly correlate with prognosis and clinical outcome. Usually, a combination of c...

(This article belongs to the Special Issue Recent Advances in Pediatric Acute Leukemia)
  • Article
  • Open Access
17 Citations
3,378 Views
19 Pages

Machine Learning Based Analysis of Relations between Antigen Expression and Genetic Aberrations in Childhood B-Cell Precursor Acute Lymphoblastic Leukaemia

  • Jan Kulis,
  • Łukasz Wawrowski,
  • Łukasz Sędek,
  • Łukasz Wróbel and ,
  • Łukasz Słota,
  • Vincent H. J. van der Velden,
  • Tomasz Szczepański and
  • Marek Sikora
  • + 3 authors+ 0 author

19 April 2022

Flow cytometry technique (FC) is a standard diagnostic tool for diagnostics of B-cell precursor acute lymphoblastic leukemia (BCP-ALL) assessing the immunophenotype of blast cells. BCP-ALL is often associated with underlying genetic aberrations, that...

(This article belongs to the Special Issue Diagnosis and Management of Blood Diseases)
  • Review
  • Open Access
3 Citations
2,725 Views
21 Pages

Age-Driven Genetic and Epigenetic Heterogeneity in B-ALL

  • Yoana Veselinova,
  • Manel Esteller and
  • Gerardo Ferrer

9 September 2025

B-cell acute lymphoblastic leukemia (B-ALL) remains a major clinical challenge in hematologic oncology, characterized by a continuous evolution of molecular drivers that shape its heterogeneity across the age spectrum. Pediatric B-ALL is generally as...

(This article belongs to the Section Molecular Genetics and Genomics)
  • Article
  • Open Access
389 Views
21 Pages

Minor Myeloid Leukemic Populations in Pediatric Acute Lymphoblastic Leukemia: A Potentially Underrecognized Mixed-Phenotype Tumor?

  • Alexandra Semchenkova,
  • Polina Lavrova,
  • Vladimir Kozeev,
  • Irina Demina and ,
  • Ekaterina Mikhailova,
  • Julia Roumiantseva,
  • Svetlana Lagoyko,
  • Anna Kazakova,
  • Galina Novichkova and
  • Alexander Popov
  • + 7 authors+ 2 authors

2 October 2026

In “bilineal” mixed-phenotype acute leukemia (MPAL), the proportions of lymphoid and myeloid leukemic cells may differ substantially. A myeloid component may constitute <10% of bone marrow (BM) cells and show subtle immunophenotypic ab...

(This article belongs to the Special Issue Molecular Pathogenesis and Treatments of Pediatric Leukemias)
  • Review
  • Open Access
19 Citations
5,928 Views
22 Pages

15 October 2021

Although childhood acute lymphoblastic leukemia (ALL) is curable, global disparities in treatment outcomes remain. To reduce these global disparities in low-middle income countries (LMIC), a paradigm shift is needed: start with curing low-risk ALL. L...

(This article belongs to the Special Issue Advance in the Treatment of Pediatric Leukemia)
  • Article
  • Open Access
1,040 Views
17 Pages

Epidemiological Profile of Pediatric Patients with Acute Lymphoblastic Leukemia Admitted to Four Hospitals in Curitiba, Southern Brazil

  • Regiane Nogueira Spalanzani,
  • Liana Alves de Oliveira,
  • Sara Cristina Lobo-Alves,
  • Thaís Muniz Vasconcelos and ,
  • Luiza Souza Rodrigues,
  • Damaris Krul,
  • Adriele Celine Siqueira,
  • Curitiba Transcriptomics and Microbiomics ALL Consortium,
  • Roberto Rosati and
  • Lorena Bavia
  • + 6 authors+ 1 author

15 June 2026

Background/Objectives: Acute lymphoblastic leukemia (ALL) is the most common childhood malignancy. Understanding its epidemiological characteristics is essential for guiding public health strategies. In this study, we characterized the epidemiologica...

(This article belongs to the Section Cancer and Cancer-Related Research)
  • Article
  • Open Access
5 Citations
3,255 Views
15 Pages

Distinct FLT3 Pathways Gene Expression Profiles in Pediatric De Novo Acute Lymphoblastic and Myeloid Leukemia with FLT3 Mutations: Implications for Targeted Therapy

  • Lizhen Zhao,
  • Hongbo Chen,
  • Fengli Lan,
  • Jinjin Hao and ,
  • Wenzhi Zhang,
  • Ying Li,
  • Yuhong Yin,
  • Minchun Huang and
  • Xiaoyan Wu
  • + 4 authors+ 0 author

4 September 2024

Activating FLT3 mutations plays a crucial role in leukemogenesis, but identifying the optimal candidates for FLT3 inhibitor therapy remains controversial. This study aims to explore the impacts of FLT3 mutations in pediatric acute lymphoblastic leuke...

(This article belongs to the Section Molecular Genetics and Genomics)
  • Article
  • Open Access
3 Citations
3,824 Views
13 Pages

Imaging Flow Cytometric Identification of Chromosomal Defects in Paediatric Acute Lymphoblastic Leukaemia

  • Ana P. A. Simpson,
  • Carly E. George,
  • Henry Y. L. Hui,
  • Ravi Doddi and ,
  • Rishi S. Kotecha,
  • Kathy A. Fuller and
  • Wendy N. Erber
  • + 2 authors+ 0 author

14 January 2025

Acute lymphoblastic leukaemia is the most common childhood malignancy that remains a leading cause of death in childhood. It may be characterised by multiple known recurrent genetic aberrations that inform prognosis, the most common being hyperdiploi...

(This article belongs to the Special Issue The Applications of Flow Cytometry: Advances, Challenges, and Trends)
  • Article
  • Open Access
947 Views
22 Pages

Integrated Genomic Profiling of Pediatric Acute Lymphoblastic Leukemia: Genomic Landscape, Risk Stratification and Association of RAS Pathway Mutations with Early Treatment Response

  • Andreea Stefan-Hodorogea,
  • Letitia Radu,
  • Andra Marcu,
  • Andreea Serbanica and ,
  • Ana Bica,
  • Cristina Jercan,
  • Ana Marcu,
  • Dumitru Jardan,
  • Cerasela Jardan and
  • Anca Colita
  • + 11 authors+ 6 authors

Acute lymphoblastic leukemia (ALL) is the most common pediatric malignancy and genomic profiling has become increasingly vital for risk stratification. We conducted a retrospective single-center study including 96 newly diagnosed pediatric patients w...

(This article belongs to the Section Molecular Genetics and Genomics)
  • Article
  • Open Access
652 Views
25 Pages

Pediatric B-Cell Acute Lymphoblastic Leukemia: Comprehensive Genomic Characterization Including SNP-Array and Analysis of Relapse Risk

  • Concepción Prats-Martín,
  • Laura Pérez Ortega,
  • Águeda Molinos Quintana,
  • Jordi Ribera and ,
  • Beatriz Chiclana Rodríguez,
  • Teresa Caballero-Velázquez,
  • Estrella Carrillo Cruz,
  • Henry Antonio Andrade-Ruiz,
  • María Paz Garrastazul Sánchez and
  • Rosario M. Morales-Camacho
  • + 9 authors+ 4 authors

14 August 2026

Background: Accurate identification of pediatric B-cell acute lymphoblastic leukemia (B-ALL) patients at increased risk of relapse remains a major clinical challenge, as relapse occurs in 10–20% of cases, including patients initially classified...

(This article belongs to the Section Cancer Causes, Screening and Diagnosis)
  • Article
  • Open Access
1 Citations
2,600 Views
20 Pages

Molecular Long-Term Analysis of the GMMG-HD4 Trial in Multiple Myeloma—Patterns of Association of Chromosomal Aberrations with Response and Proliferation Determining Survival in Selecting Treatments in View of Limited Resources in Low- and Middle-Income Countries

  • Anja Seckinger,
  • Hans Salwender,
  • Hans Martin,
  • Christof Scheid and ,
  • Thomas Hielscher,
  • Uta Bertsch,
  • Manuela Hummel,
  • Anna Jauch,
  • Wolfgang Knauf and
  • Dirk Hose
  • + 18 authors+ 13 authors

Based on the lack of differences in progression-free and overall survival after a median follow-up of 93 months in our HOVON-65/GMMG-HD4 trial (German part; n = 395) randomizing VAD induction (vincristin/adriamycin/dexamthasone)/tandem-transplantatio...

(This article belongs to the Section Molecular Oncology)